Status:
UNKNOWN
Beneficial Effect of Pulmonary Rehabilitation in Lung Cancer Patients Receiving Radiation Therapy
Lead Sponsor:
Asan Medical Center
Conditions:
Lung Neoplasm Malignant
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
It is important for clinicians to maintain and support for exercise capacity and quality of life of lung cancer patients after radiation therapy, because radiation therapy also affect the lung functio...
Detailed Description
Roles of the radiation therapy in lung cancer are as followings; 1) to treat the lung caner stage 1 \~2 patients, who are inadequate for operation due to declined lung function, 2) to treat the locall...
Eligibility Criteria
Inclusion
- Lung cancer patients with scheduled radiation therapy (postoperative adjuvant radiation therapy and concurrent chemoradiation therapy) during more than 4 weeks (5 times a week, 20 times a week)
- Lung parenchymal cancer
- Consent to regular outpatient-based pulmonary rehabilitation program, considering residence and other factors.
Exclusion
- Communication restrictions
- Failed to obtain consent form
- Accompanied by psychiatric problems or severe dizziness
- Patients have comorbidities, which are regarded as contraindications of pulmonary rehabilitation, such as severe pulmonary hypertension or hemodynamic instability
Key Trial Info
Start Date :
June 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05414188
Start Date
June 14 2022
End Date
December 31 2023
Last Update
June 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan Medical Center, University of Ulsan College of Medicine
Seoul, Songpa, South Korea, 05505